Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, single-center, two-period, two-sequence crossover study to
assess the bioequivalence of SP-01 (Sancuso®: Granisetron Patch) manufactured at two
different sites. Either the test product, namely SP-01-K, or reference product, namely
SP-01-A, will be applied to the subject once in each period.